Projected Prostate Cancer Incidence in the Middle East by 2050: Socioeconomic Disparities and Future Implications
Prostate cancer incidence in the Middle East is expected to rise substantially by 2050, with socioeconomic disparities influencing disease trends. These findings highlight the urgent need for targeted awareness campaigns, improved screening strategies, enhanced oncology infrastructure, and strengthened cancer registries to mitigate the projected burden and improve outcomes in the region.
Authors
- Ömer Burak Argun (ORCID: https://orcid.org/0000-0003-0127-0005)
- Mutlay Sayan (ORCID: https://orcid.org/0000-0002-0101-0951)
- Jonathan E. Leeman (ORCID: https://orcid.org/0000-0003-4539-0762)
- Miranda B. Lam (ORCID: https://orcid.org/0000-0001-7885-6317)
- Layth Mula‐Hussain (ORCID: https://orcid.org/0000-0003-0218-7270)
- Luke W. Chen
- Nadeem Pervez
- Yetkin Tuaç (ORCID: https://orcid.org/0000-0001-6590-3233)
- Özlem Aynaci (ORCID: https://orcid.org/0000-0002-1799-5521)
- Joseph E. Parisi
- Gary P. Kearney
Institutions
- University of Mosul (IQ)
- Brigham and Women's Hospital (US)
- Dalhousie University (CA)
- Harvard University (US)
- Ankara University (TR)
- Karadeniz Technical University (TR)
- Dana-Farber Cancer Institute (US)
- Dana-Farber Brigham Cancer Center (US)
Publication Details
- Journal
- JCO Global Oncology
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1200/go-25-00098
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00